Modern Drug Delivery Technologies for the Cancer Therapy - Bagiyal, Dr. Pawan;Rajwar, Sonam
47,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
24 °P sammeln
  • Broschiertes Buch

The book "Modern Drug Delivery Technologies in the Cancer Therapy" covers the latest breakthroughs in nanomedicine and nano-based drug delivery systems for the management of malignancies of the blood, lungs, brain, and kidneys. Early chapters provide a quick overview of the science behind cancer. Next, we'll take a look at the state of cancer pharmacotherapy as it is right now. A case is made for the use of cutting-edge drug delivery systems in oncology and cancer therapy, and the methods applicable to a variety of malignancies are then examined. Anybody in academia, research, or industry…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The book "Modern Drug Delivery Technologies in the Cancer Therapy" covers the latest breakthroughs in nanomedicine and nano-based drug delivery systems for the management of malignancies of the blood, lungs, brain, and kidneys. Early chapters provide a quick overview of the science behind cancer. Next, we'll take a look at the state of cancer pharmacotherapy as it is right now. A case is made for the use of cutting-edge drug delivery systems in oncology and cancer therapy, and the methods applicable to a variety of malignancies are then examined. Anybody in academia, research, or industry involved in cancer biology or drug delivery will find Modern Drug Delivery Technologies in the Cancer Therapy to be an indispensable resource. Drug formulation and drug delivery specialists, as well as cancer biologists and translators, will find this book valuable.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Pawan Bagiyal arbeitet derzeit als stellvertretender Manager bei AMRIT PHARMACY, das mit HLL Lifecare Limited, AIIMS Rishikesh, Uttarakhand, Indien, verbunden ist. Dr. Pawan Bagiyal hat ein Studium, eine Promotion und einen Doktortitel in Pharmazeutischen Wissenschaften absolviert. Er verfügt über ein umfangreiches Wissen über verschiedene Ansätze zur Verabreichung von Medikamenten bei unterschiedlichen Krankheiten, insbesondere bei Leberkrebs.